ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,031Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 676

$1.71M Total Retail Price of All Prescriptions

Rank: 10 out of 676

871 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 871 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 14,045 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
SIMVASTATIN 945 571 1 6
GABAPENTIN 795 286 2 10
ZOLPIDEM TARTRATE 786 215 3 21
METFORMIN HCL 726 381 4 8
TIZANIDINE HCL 706 223 5 68
HYDROCODONE-ACETAMINOPHEN 697 242 S3 6 1
OMEPRAZOLE 659 322 7 2
LISINOPRIL 630 335 8 5
AMLODIPINE BESYLATE 582 324 9 3
CARVEDILOL 577 296 10 15
LEVOTHYROXINE SODIUM 515 281 11 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 510 221 12 16
FUROSEMIDE 449 243 13 4
DIOVAN HCT 447 281 14 41
TRAMADOL HCL 443 163 15 19
NEXIUM 442 242 16 23
HYDROCODONE BIT-IBUPROFEN 391 134 S3 10 17 237
POTASSIUM CHLORIDE 329 178 18 9
ATORVASTATIN CALCIUM 302 141 19 20
SULFAMETHOXAZOLE-TRIMETHOPRIM 293 131 20 74
ALLOPURINOL 292 149 21 31
CRESTOR 277 135 22 29
PRAVASTATIN SODIUM 269 111 23 11
METOPROLOL SUCCINATE 268 174 24 14
CYMBALTA 268 101 24 47
CLONIDINE HCL 266 168 26 32
LOSARTAN-HYDROCHLOROTHIAZIDE 258 145 27 51
CLOPIDOGREL 252 185 28 28
WARFARIN SODIUM 251 106 29 18
CITALOPRAM HBR 218 115 30 17
HYDROCHLOROTHIAZIDE 209 96 31 12
MIRTAZAPINE 208 79 32 59
CYCLOBENZAPRINE HCL 199 41 R 33 50
PLAVIX 195 156 34 40
LYRICA 192 44 35 57
FLUTICASONE PROPIONATE 192 74 35 49
AMLODIPINE BESYLATE-BENAZEPRIL 190 116 37 44
KLOR-CON 10 178 127 38 95
LOSARTAN POTASSIUM 176 136 39 34
JANUMET 176 102 39 167
FLUCONAZOLE 174 52 41 115
PROMETHAZINE HCL 171 52 R 42 75
CIPROFLOXACIN HCL 170 106 43 45
DIOVAN 169 111 44 37
MELOXICAM 164 106 45 13
PROAIR HFA 163 75 46 79
METOPROLOL TARTRATE 153 84 47 22
METFORMIN HCL ER 150 65 48 63
SYNTHROID 146 82 49 48
MECLIZINE HCL 142 90 50 83
CLOTRIMAZOLE-BETAMETHASONE 141 75 51 170
VENTOLIN HFA 141 61 51 127
ATENOLOL 140 95 53 25
CEPHALEXIN 139 60 54 84
LOVASTATIN 139 110 54 33
TRIAMTERENE-HCTZ 138 63 56 43
TRICOR 133 80 57 126
IBUPROFEN 127 48 58 102
JANUVIA 126 78 59 78
BUSPIRONE HCL 124 77 60 113
FLUOXETINE HCL 119 65 61 70
BENAZEPRIL HCL 119 85 61 58
COMBIVENT 118 47 63 174
RANITIDINE HCL 118 43 63 27
AMOXICILLIN 116 40 65 105
RAMIPRIL 113 75 66 86
ISOSORBIDE MONONITRATE ER 111 62 67 54
LANSOPRAZOLE 109 38 68 171
SPIRONOLACTONE 108 70 69 62
AZITHROMYCIN 107 41 70 39
GLIMEPIRIDE 106 66 71 30
KLOR-CON M20 105 51 72 67
METHYLPREDNISOLONE 105 57 72 124
MUPIROCIN 105 55 72 146
DOXYCYCLINE HYCLATE 104 53 75 82
CARISOPRODOL 102 16 R 76 60
PREDNISONE 102 45 76 53
PHENYTOIN SODIUM EXTENDED 101 40 78 88
VALACYCLOVIR 100 52 79 292
CEFADROXIL 100 58 79 258
TRAZODONE HCL 99 33 81 36
TAMSULOSIN HCL 99 65 81 38
VENLAFAXINE HCL ER 99 41 81 98
GLYBURIDE-METFORMIN HCL 98 96 R 84 76
NAMENDA 97 97 85 35
DIGOXIN 93 62 86 52
TORSEMIDE 88 24 87 159
NIASPAN 87 22 88 162
CILOSTAZOL 85 32 89 123
TRIAMTERENE-HYDROCHLOROTHIAZID 85 35 89 160
SERTRALINE HCL 84 16 91 26
MOMETASONE FUROATE 83 39 92 296
DICLOFENAC SODIUM 80 58 93 142
ADVAIR DISKUS 79 38 94 87
PANTOPRAZOLE SODIUM 78 38 95 42
LIPITOR 77 55 96 94
POLYETHYLENE GLYCOL 3350 76 48 97 56
NOVOLOG MIX 70-30 FLEXPEN 76 28 97 307
SINGULAIR 74 12 99 80
VICTOZA 3-PAK 74 22 99 332
VALSARTAN-HYDROCHLOROTHIAZIDE 74 40 99 281
PREMARIN 72 24 R 102 128
AMITRIPTYLINE HCL 71 39 R 103 46
DONEPEZIL HCL 70 69 104 24
NOVOLOG FLEXPEN 68 16 105 226
ESTRADIOL 68 23 R 105 109
ACYCLOVIR 67 0 107 339
SEROQUEL XR 66 11 108 244
BYSTOLIC 66 37 108 96
ENALAPRIL MALEATE 66 0 108 65
ESCITALOPRAM OXALATE 65 20 111 73
VERAPAMIL ER 63 36 112 101
SYMBICORT 62 33 113 189
SPIRIVA 62 28 113 97
DEXILANT 61 0 115 155
COUMADIN 61 33 115 193
NOVOLOG 61 20 115 134
CELEBREX 59 31 118 108
DILTIAZEM 24HR CD 58 43 119 152
NAPROXEN 58 17 119 71
QUETIAPINE FUMARATE 57 0 121 72
PAROXETINE HCL 57 30 121 65
AVODART 56 43 123 199
LANTUS 56 52 123 55
ENABLEX 52 30 125 268
LEVEMIR FLEXPEN 51 14 126 192
PRAMIPEXOLE DIHYDROCHLORIDE 50 0 127 204
AMIODARONE HCL 50 23 127 154
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 13, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.